|
COGT Cogent Biosciences Inc 1622229 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-97,352,000.00 |
| Balance Sheet |
|
Current Assets
|
$877,803,000.00 |
|
Assets
|
$903,006,000.00 |
|
Current Liabilities
|
$57,981,000.00 |
|
Liabilities
|
$295,313,000.00 |
|
Equity
|
$607,693,000.00 |
|
Shares Out
|
170773803.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-86,883,000.00 |
|
Investing Cash Flow
|
$-36,457,000.00 |
| Market Analysis |
Market Cap
|
$7,063,204,492.08 |
|
Price
|
$37.93 |
|
BVPS
|
3.56 |
|
PB
|
11.62 |
|
EPS
|
-0.53 |
|
FCF
|
$-87,332,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:13 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COGT documents filed with the SEC.
COGT Filings
Clear
